CLRB (Cellectar Biosciences) Institutional Ownership: 5.00% (As of Jul. 05, 2026)


CLRB Cellectar Biosciences Inc CLRB
23 GF Score
Price $2.81
! 1 Warning Sign
View Full Analysis

What is Cellectar Biosciences Institutional Ownership?

Cellectar Biosciences CLRB -0.71% 23 Institutional Ownership is 5.00% as of Jul. 05, 2026. GuruFocus rates CLRB with a GF Score™ of 23/100. The stock has 1 warning sign investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Cellectar Biosciences's institutional ownership is 5.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Cellectar Biosciences's Insider Ownership is 7.37%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Cellectar Biosciences's Float Percentage Of Total Shares Outstanding is 99.63%.

Cellectar Biosciences Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Cellectar Biosciences's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cellectar Biosciences Institutional Ownership Chart

Cellectar Biosciences Historical Data

The historical data trend for Cellectar Biosciences can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 4.60 4.79 3.63 3.88 4.15 4.23 4.68 4.52 2.29 2.29
CLRB
23GF Score
Cellectar Biosciences Inc CLRB
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cellectar Biosciences Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 5.00% mean?
Cellectar Biosciences (CLRB) has a Institutional Ownership of 5.00% as of Jul. 05, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Cellectar Biosciences and its competitors.
Is Cellectar Biosciences' Institutional Ownership too high?
Cellectar Biosciences' current Institutional Ownership is 5.00%. Overall, Cellectar Biosciences has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Cellectar Biosciences' Institutional Ownership compare to OTLC and PTN?
Cellectar Biosciences' Institutional Ownership of 5.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Cellectar Biosciences and its competitors. Cellectar Biosciences's current Institutional Ownership is 5.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cellectar Biosciences stock overvalued right now?
Cellectar Biosciences (CLRB) has a current Institutional Ownership of 5.00%. The current Institutional Ownership is 5.00%. Cellectar Biosciences' overall GF Score™ is 23/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Cellectar Biosciences (CLRB), the current Institutional Ownership is 5.00% as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cellectar Biosciences Business Description

Address 100 Campus Drive, Florham Park, NJ, USA, 07932
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. The products under development include Iopofosine, CLR 121125 ,CLR 121225 and others. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.
23GF Score

Get the complete analysis for CLRB

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.81
Price